Share Prices & Company Research

Market News

08 Mar 2021 | 12:19

Amryt Pharma signs another distribution deal with Medison

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced the signing of a distribution agreement with Medison Pharma to distribute 'Myalepta' in Canada on Monday. The AIM-traded firm said the agreement completed the multi-regional distribution deals with Medison, first announced in February, to distribute Myalepta, or metreleptin, and 'Lojuxta', or lomitapide, in Israel, and 'Juxtapid', or lomitapide in Canada.

"Today's announcement represents continued progress as we grow our commercial assets and expand access to treatment for patients in existing and new territories," said chief executive officer Dr Joe Wiley.

"We are also pleased to extend our engagement with Medison and further benefit from their expertise in Canada and other territories."

At 1140 GMT, shares in Amryt Pharma were down 0.49% in London at 204p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.